Publications by authors named "David D Manning"

Claim this Profile
C
CSTI-300 (SMP-100); a Novel 5-HT Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome.
Alexander Roberts, Gillian Grafton, Andrew D Powell, Kristian Brock, Chunlin Chen, David D Manning

J Pharmacol Exp Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitors.
John Wityak, Kevin F McGee, Michael P Conlon, Ren Hua Song, Bryan C Duffy, David D Manning

J Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of diazepinone-based 5-HT3 receptor partial agonists.
David D Manning, Cheng Guo, Zhenjun Zhang, Kristen N Ryan, Jennifer Naginskaya

Bioorg Med Chem Lett· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial agonism of 5-HT3 receptors: a novel approach to the symptomatic treatment of IBS-D.
Nicholas A Moore, Bruce J Sargent, David D Manning, Peter R Guzzo

ACS Chem Neurosci· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.
David D Manning, Christopher L Cioffi, Alexander Usyatinsky, Kevin Fitzpatrick, Liaqat Masih

Bioorg Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.
Zhicai Yang, David J Fairfax, Jun-Ho Maeng, Liaqat Masih, Alexander Usyatinsky, David D Manning

Bioorg Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI.
Jailall Ramnauth, Mathew D Surman, Peter B Sampson, Bryan Forrest, Jeff Wilson, David D Manning

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of vinca alkaloid analogues.
Matthew E Voss, Jeffery M Ralph, Dejian Xie, David D Manning, Xinchao Chen

Bioorg Med Chem Lett· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboxylate bioisosteres of pregabalin.
Jacob B Schwarz, Norman L Colbry, Zhijian Zhu, Brian Nichelson, Nancy S Barta, David D Manning

Bioorg Med Chem Lett· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis